The DOI matches its Crossref record.
Epibatidine, a potent analgetic and nicotinic agonist.
Abstract
Synthetic (+)- and (-)-epibatidine (an alkaloid originally characterized from frog skin) have potent analgetic activity in mice, using the hot-plate assay. The natural (+)-enantiomer, with an ED50 of about 1.5 micrograms/kg upon intraperitoneal injection, is about 2-fold more potent than the (-)-enantiomer. The analgetic activity is blocked by the nicotinic antagonist mecamylamine. Both the (+)- and (-)-enantiomers have high affinity (Ki values of 0.045 and 0.058 nm, respectively) for nicotinic sites that bind [3H] nicotine in rat brain membranes. An analog of epibatidine with the chloro substituent of the pyridyl ring replaced with hydrogen has comparable affinity for nicotinic sites, whereas replacement with a methyl or iodo substituent lowers activity. Both (+)- and (-)-epibatidine have potent agonist activity at ganglionic-type nicotinic receptors in pheochromocytoma PC-12 cells, with EC50 values for stimulation of sodium influx of 72 and 111 nM, respectively. (-)-Epibatidine is about 5-fold less potent as an agonist at muscle-type central nicotinic receptors of medulloblastoma TE671 cells. It would appear that the analgetic activity of epibatidine is due to activity as a nicotinic agonist. The epibatidines have little or no activity at a variety of other central receptors, including opioid receptors, muscarinic receptors, adrenergic receptors, dopamine receptors, serotonin receptors, and gamma-aminobutyric acid receptors.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
NEONICOTINOID INSECTICIDE TOXICOLOGY: Mechanisms of Selective Action
Tomizawa, M., & Casida, J. E. (2005) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.45.120403.095930 · Cited by 1,741
Nicotine stimulates angiogenesis and promotes tumor growth and atherosclerosis
Heeschen, C., Jang, J. J., Weis, M., Pathak, A., Kaji, S., Hu, R. S., Tsao, P. S., Johnson, F. L., & Cooke, J. P. (2001) · Nature Medicine · doi:10.1038/89961 · Cited by 800
Therapeutic potential of venom peptides
Lewis, R. J., & Garcia, M. L. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1197 · Cited by 798
Competition in Retinogeniculate Patterning Driven by Spontaneous Activity
Penn, A. A., Riquelme, P. A., Feller, M. B., & Shatz, C. J. (1998) · Science · doi:10.1126/science.279.5359.2108 · Cited by 514
Nicotinic receptors in the brain: correlating physiology with function
Jones, S., Sudweeks, S., & Yakel, J. L. (1999) · Trends in Neurosciences · doi:10.1016/s0166-2236(99)01471-x · Cited by 450
Metadata
- Authors
- Badio, B., & Daly, J. W.
- Venue
- Molecular Pharmacology
- Publisher
- Elsevier BV
- Published
- 1994-04
- Volume
- 45
- Issue
- 4
- Pages
- 563-569
- ISSN
- 0026-895X (ISSN-L)
- OpenAlex
- W1751000605
- Cited by
- 388
- References
- 0
- FWCI
- 7.84
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Epibatidine, a potent analgetic and nicotinic agonist. https://app.cochat.ai/papers/10.1016/s0026-895x(25)10139-9
- The paper
- Badio, B., & Daly, J. W. (1994). Epibatidine, a potent analgetic and nicotinic agonist. Molecular Pharmacology. https://doi.org/10.1016/s0026-895x(25)10139-9
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.